Address
BioHub Birmingham
97 Vincent Drive
Birmingham
West Midlands B15 2SQ
United Kingdom
Contact
Paul Thompson+4407525390335
paul.thompson@matokeholdings.com
Website
Reactive Oxygen®
A novel and potent antimicrobial with broad spectrum efficacy including against MDR pathogens.
Reactive Oxygen® provides broad spectrum antimicrobial efficacy including against MDR organisms, destroys biofilm and promotes wound healing.
Technology:
Microorganisms:
Application:
Development stage:
- Infection prevention
- Antimicrobial stewardship
- Antimicrobial compound/strategy
- Microbial diagnostics
- Removal antibiotics/bacteria
Microorganisms:
- Bacteria
- Fungi
- Yeasts
- Viruses
- Parasites
Application:
- Human
- Veterinary
- AgriFood
- Environmental
- Other
Development stage:
- Development
- Validation
- Research
- Market entry
- Marketed product
Organization:
Partnering:
Funding organisation:
Infectious disease area:
Geographic origin:
- Company
- Academia
- Institute
- NGO
- Government
Partnering:
- License
- Co-develop
- Sell
- Outsource
- Joint Venture
Funding organisation:
- OTHER / NA
- CARB-X
- FIND
- GARDP
- REPAIR
Infectious disease area:
- UTI
- RTI
- SSTI
- SSI
- STI
- BSI
- GII
- CNSI
- IAI
Geographic origin:
- Eurasia
- North America
- South America
- Africa
- Oceania
Medical device businesses with a wound care portfolio and models for sharing expertise and making investments to allow new products to be brought to market more quickly as part of a broader collaboration strategy.
Matoke’s Reactive Oxygen® antimicrobial products treat a range of clinical indications and contribute to the fight against Anti-Microbial Resistance.
None
